New York Cancer and Blood Specialists

What New York Cancer and Blood Specialists does

New York Cancer and Blood Specialists (NYCBS) is a physician-owned, professionally managed multi-specialty group practice delivering community-based oncology and hematology care across 40+ locations throughout New York City, Long Island, Queens, Brooklyn, the Bronx, Staten Island, the Hamptons, and the Hudson Valley. The practice was founded around 1970 (firmographic data lists 1996) and has grown to include 100+ board-certified physician specialists and 1,001–5,000 total employees, making it one of the largest community oncology practices in the nation. CEO Dr. Jeff Vacirca is also a co-founder of OneOncology, signaling affiliation with a broader independent oncology network.

NYCBS operates a comprehensive clinical platform spanning medical oncology, hematology, radiation oncology (including CyberKnife precision therapy), infusion services, diagnostic imaging (X-ray, CT, MRI, PET), in-house laboratory testing, surgical oncology, palliative care, an on-site specialty pharmacy, and access to NCI-approved clinical trials. The underlying technology stack includes Flatiron Health's EMR and patient portal (redirecting to CareSpace), Healthix Regional Health Information Organization participation within SHIN-NY for cross-provider record exchange, an AI-powered Patient Navigator chatbot (NLP/knowledge retrieval) for patient-facing inquiries, and recently integrated third-party platforms: Talkiatry Connect (an EMR-embedded psychiatric referral product supporting 30+ cloud EMRs), Agilix Health (a virtual nutrition-led supportive care platform synced with the EHR), and OncoveryCare (survivorship care clinicians). The practice has achieved a perfect 100/100 score on CMS MIPS for 2025 and ACR reaccreditation for its radiation oncology division.

The business model is fee-for-service healthcare delivery billed through insurance, supplemented by professional-services revenue from sponsored clinical trials and transaction-fee revenue from the in-house pharmacy. Go-to-market is sales-led and referral-driven: patients are acquired via physician referrals, hospital partnerships, insurance network participation, and direct appointment requests through phone, Sherpa Health, and Zocdoc. The practice accepts most major insurance plans. Patient segmentation is use-case based, with primary segments being cancer patients, hematology patients, and secondary segments including oncology patients with mental health needs (up to 25% experience clinical depression per Talkiatry partnership data) and cancer survivors. Long-term survivorship care is an emerging segment tied to a growing US survivor population projected to expand from 18 million in 2022 to 26 million by 2040.

Name

New York Cancer and Blood Specialists

Legal name

New York Cancer & Blood Specialists

Website

https://nycancer.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

New York Cancer and Blood Specialists is a physician-owned community oncology practice operating 40+ locations across New York, delivering comprehensive cancer and hematology care—including medical, radiation, and surgical oncology, infusion, imaging, lab, pharmacy, and clinical trials—to patients across NYC, Long Island, Hudson Valley, and surrounding regions.

Ownership category

akta.pro rank

Product category

Community Oncology Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Infusion Therapy Centers (Outpatient) (HLAFABAF)

Keywords

• Community oncology services
• Hematology oncology care
• Cancer treatment centers
• Radiation oncology services
• Oncology clinical trials

Headquarters

HQ city

Bay Shore

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Patient Care Services: Fee-for-service healthcare delivery including medical oncology, hematology, infusion therapy, radiation oncology, imaging, lab testing, and surgical services. Revenue generated through insurance billing and patient payments based on services rendered.
2. Clinical Trials: Revenue from sponsored clinical trials including NCI-approved trials and industry-sponsored research studies.
3. In-House Pharmacy: On-site pharmacy services providing medications to patients undergoing treatment.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

New York Cancer and Blood Specialists is a community oncology practice providing comprehensive cancer and blood disorder care through 40+ locations across New York State, staffed by 100+ board-certified physicians. The practice delivers medical oncology, hematology, radiation oncology, infusion therapy, surgical oncology, diagnostic imaging, in-house laboratory testing, palliative care, in-house pharmacy, clinical trials, and supportive services such as survivorship care, mental health integration, and personalized nutrition programs.

Product overview

New York Cancer & Blood Specialists operates as a comprehensive community oncology practice offering a unified platform of cancer and blood disorder care services. The core offering encompasses Medical Oncology, Hematology, Radiation Oncology, Infusion Services, Diagnostic Imaging, Laboratory Testing, Surgical Oncology, Clinical Trials, and Palliative Care—all provided across 40+ locations throughout New York. The practice differentiates through ancillary support services including an in-house pharmacy, nutrition care program (powered by Agilix Health), and survivorship care (via OncoveryCare partnership). An AI-powered Patient Navigator chatbot provides patient-facing digital assistance. Mental health integration through Talkiatry extends whole-person care capabilities. The practice maintains in-house laboratory and radiology facilities for seamless diagnostics and coordinates with hospital partners while delivering community-based care.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Perfect 100/100 score in CMS Merit-based Incentive Payment System (MIPS) for 2025
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability3 records

Feature3 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• TalkiatrycoreStrategic or Co-development Partner · 29 April 2026Talkiatry partnered with NYCBS to provide integrated psychiatric care to oncology and hematology patients across more than 30 NYCBS locations in New York. The collaboration leverages Talkiatry's network of over 300 board-certified psychiatrists to offer both in-person and virtual consultations, addressing the significant mental health burden on cancer patients where up to 25% experience clinical depression. The partnership includes seamless referral workflows and accepts most major insurance plans.
• TalkiatrycoreTechnology or Integration · 9 April 2026Talkiatry Connect, a referral product embedded within cloud-based electronic medical record systems, is in use at NYCBS enabling care teams to coordinate psychiatric support for patients undergoing complex oncology treatment. The tool supports 30+ cloud-based EMRs including Athenahealth, eClinicalWorks, Practice Fusion, and Elation.
• Agilix HealthcoreStrategic or Co-development Partner · 3 December 2025Launched New York State's first virtual, nutrition-led supportive care program in collaboration with Agilix Health. Each patient is paired with a registered dietitian at diagnosis with connected monitoring tools for ongoing assessment. The program provides personalized nutrition support adapted throughout each patient's treatment journey to prevent malnutrition and help patients tolerate therapy better.
• OncoveryCarecoreStrategic or Co-development Partner · 25 September 2025Partnership with OncoveryCare to provide personalized, ongoing survivorship care to NYCBS survivor population. OncoveryCare's survivorship-trained clinicians treat chronic and late-effects of cancer treatment including fatigue, joint pain, sexual dysfunction, insomnia, and anxiety. The collaboration addresses the growing need for comprehensive survivorship care as cancer survivor populations increase.
• Healthix / SHIN-NYcoreTechnology or IntegrationNYCBS participates in the Regional Health Information Organization (RHIO) that is part of the Statewide Health Information Network for New York (SHIN-NY). This network allows healthcare providers to securely share medical records to coordinate patient care.
• New York HealthminorStrategic or Co-development PartnerPartner organization providing complementary healthcare services including urology and other specialty care across New York locations.
• New York ImagingminorStrategic or Co-development PartnerPartner organization providing diagnostic imaging services complementary to NYCBS oncology services.
• New York Breast HealthminorStrategic or Co-development PartnerPartner organization specializing in breast health services supporting NYCBS cancer care services.
• New York Cancer FoundationminorOthersNon-profit foundation supporting NYCBS patients and cancer care initiatives in New York communities.
• Mondays Cancer CareminorStrategic or Co-development PartnerPartnership providing wellness suite at Port Jefferson facility offering free services to patients including oncology massage, skincare, and beauty treatments to support overall well-being during treatment.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ASTERA Cancer Care: Large community oncology practice serving New Jersey and surrounding regions with medical oncology, hematology, radiation, and infusion services. Operates in adjacent geography to NYCBS with a comparable multi-specialty community oncology model.
• Texas Oncology: Part of the US Oncology Network, Texas Oncology operates 200+ sites across Texas with hundreds of physicians offering medical oncology, radiation, infusion, imaging, and clinical trials. Same community-based, multi-site model as NYCBS at meaningfully larger scale.
• Florida Cancer Specialists & Research Institute: One of the largest independent, physician-owned community oncology practices in the U.S., operating ~100 locations across Florida with 250+ physicians. Closest direct comparable to NYCBS in model, scale, and service breadth, but operating in a different geography.
• The Oncology Institute: Public community oncology practice (NASDAQ: TOI) operating 70+ clinics across multiple states with a similar medical-oncology, infusion, and clinical-trials offering. Direct competitive model to NYCBS, differing primarily in multi-state footprint and public capital structure.

Broad incumbents

• US Oncology Network (McKesson): Subsidiary of McKesson and one of the largest community oncology networks in the U.S., providing technology, distribution, and operational infrastructure to affiliated practices. Larger, broader-scale competitor and potential partner for NYCBS.
• Northwell Health Cancer Institute: Large New York-based health system cancer program operating across the same geographic footprint as NYCBS, combining hospital-based and community oncology. Represents both a hospital-partner relationship and a competitor for community oncology patients.
• Memorial Sloan Kettering Cancer Center: Premier academic cancer center operating in the same New York metropolitan market as NYCBS. Competes for complex oncology cases and clinical trials, and is a referral partner for cases that exceed community capabilities.

Others

• OneOncology: National network of independent community oncology practices co-founded by NYCBS CEO Dr. Jeff Vacirca. Functions as a platform partner providing technology, drug purchasing, and operational support to affiliated practices including NYCBS, with strategic implications for its growth trajectory.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat7 records

Key highlights7 records

Customer concentration

• Xx.com/newyorkcancer
• Facebookfacebook.com/newyorkcancer
• LinkedInlinkedin.com/company/new-york-cancer-blood-specialists
• Instagraminstagram.com/team_nycbs

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New York Cancer and Blood Specialists